Technicals Say eFFECTOR Therapeutics Inc. (EFTR) Is A Hold

eFFECTOR Therapeutics Inc. (NASDAQ:EFTR) trading with an addition of $1.39 to $12.87 on Friday, an upside of 12.11 percent. An average of 655,609 shares of common stock have been traded in the last five days. There was a fall of -$0.61 in the past week. The last 20 days have seen an average of 924,642 shares traded, while the 50-day average volume stands at 2,047,575.

EFTR stock has decreased by -57.75% in the last month. The company shares reached their 1-month lowest point of $10.86 on 10/06/21. Shares of the company touched a low of $8.33 and a high of $40.42 in 52 weeks. In spite of this, the price is down -68.16% from the 52-week high.


3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Sponsored


Valuation Metrics

eFFECTOR Therapeutics Inc. (EFTR) has a trailing price-to-earnings (P/E) ratio of 34.65 for the broader industry and 31.97 for the sector. This means investors are optimistic about the stock’s future prospects. Other valuation ratios to consider include the trailing price-to-sales (P/S) ratio at 381.35, the price-to-book (PB) ratio at 1.60.

The quick ratio of eFFECTOR Therapeutics Inc. for the recent quarter was 0.70, and the current ratio was 0.70, indicating that the company is able to meet its debt obligations. Further, the company has a long term debt to equity ratio of 0.00 and a total debt to equity ratio of 0.00 for the recent quarter. eFFECTOR Therapeutics Inc.’s EBITDA margin is 38.05%.

Technical Picture

From a technical analysis perspective, let’s take a brief look at eFFECTOR Therapeutics Inc. (EFTR) price momentum. RSI 9-day as of the close on 07 October was 38.55%, suggesting the stock is Neutral, with historical volatility in this time frame at 106.87%.

As of today, EFTR’s price is $11.94 -4.64% or -$0.61 from its 5-day moving average. EFTR is currently trading -52.84% lower than its 20-day SMA and +28.35% higher than its 100-day SMA. However, the stock’s current price level is +26.91% above the SMA50.

The stochastic %K and %D were 7.69% and 6.17%, respectively, and the average true range (ATR) was 2.58. With the 14-day stochastic at 13.84% and the average true range at 2.97, the RSI (14) stands at 42.87%. The stock has reached -1.07 on the 9-day MACD Oscillator while the 14-day reading was at -2.97.

Analyst Ratings

Mizuho launched coverage on eFFECTOR Therapeutics Inc. (NASDAQ: EFTR) in its analyst report released on October 04, 2021. The firm assigned the stock a a Buy rating.The consensus rating for eFFECTOR Therapeutics Inc. (EFTR) among analysts is Overweight. According to current brokerage recommendations, 0 brokerage firms advise that investors sell EFTR, while 1 suggest investors hold. There are 0 analysts who rate the stock as underweight. The stock is rated overweight by 0 analysts, while 3 others rate it as a “buy”.

What is EFTR’s price target for the next 12 months?

Analysts predict a range of price targets between $20.00 and $50.00, with a median target of $26.50. Taking a look at these predictions, the average price target given by analysts for eFFECTOR Therapeutics Inc. (EFTR) stock is $30.75.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

spot_img

Hot Topics

Related Videos

Related Videos

Related Articles

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

592

100% free. stop anytime no spam